Core Scientific (CORZ) vs Amdocs (DOX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Core Scientific (CORZ) has outperformed Amdocs (DOX) over the past year, losing 14.6% versus a loss of 28.1%. Amdocs is the larger company by market cap ($6.14 billion vs $4.95 billion), about 1.2 times the size. On valuation, Amdocs trades at a lower forward P/E (7.3x vs 94.7x for Core Scientific).
Amdocs pays a dividend yielding 3.73%, while Core Scientific does not currently pay one. Amdocs converts more of its revenue into profit, with a net margin of 9.9% versus -90.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CORZ | DOX |
|---|---|---|
| Share price | $15.41 | $58.84 |
| Market cap | $4.95B | $6.14B |
| 1-day change | +0.33% | -2.33% |
| YTD return | +5.84% | -26.92% |
| 1-year return | -14.58% | -28.07% |
| 5-year return | — | -27.05% |
| P/E ratio (TTM) | — | 13.98 |
| Forward P/E | 94.68 | 7.33 |
| EPS (TTM) | $-4.25 | $4.21 |
| Dividend yield | 0.00% | 3.73% |
| Annual dividend | $0.00 | $2.19 |
| Revenue (latest FY) | $319.02M | $5.00B |
| Revenue growth (YoY) | -37.53% | +2.40% |
| Net income (latest FY) | $-288.62M | $493.20M |
| Gross margin | 11.88% | 35.07% |
| Operating margin | -76.98% | 12.56% |
| Net margin | -90.47% | 9.85% |
| 52-week high | $30.46 | $85.63 |
| 52-week low | $13.36 | $49.74 |
| Distance from 52-week high | -49.41% | -31.29% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +114.47% | +34.69% |
| Average volume | 11.91M | 1.13M |
| Shares outstanding | 321.34M | 104.42M |
| Employees | 325 | 26,969 |
| Sector | Finance | Technology |
| Industry | Finance: Consumer Services | EDP Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CORZ has outperformed DOX by 13.5 percentage points over the past year.
- Amdocs offers a meaningfully higher dividend yield (3.73% vs 0.00%).
- Amdocs is more profitable, keeping 9.9 cents of every revenue dollar as net income versus -90.5 cents for Core Scientific.
- Amdocs grew revenue faster in its latest fiscal year (+2.40% vs -37.53%).
- The two companies sit in different sectors: Core Scientific in Finance and Amdocs in Technology.
About Core Scientific
CORZ stock →Core Scientific, Inc. provides infrastructure for high-density colocation services and digital asset mining in the United States.
Finance · Finance: Consumer Services · 325 employees
About Amdocs
DOX stock →Amdocs Limited, through its subsidiaries, provides software and services to communications, entertainment, media, and other service providers worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud offering.
Technology · EDP Services · 26,969 employees
CORZ vs DOX FAQ
Which is bigger, Core Scientific or Amdocs?
Amdocs (DOX) is larger, with a market capitalization of $6.14B compared with $4.95B for Core Scientific (CORZ).
Which stock has performed better over the past year, CORZ or DOX?
CORZ returned -14.58% over the past 12 months, compared with -28.07% for DOX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Core Scientific or Amdocs?
Amdocs pays a dividend yielding 3.73%, while Core Scientific does not currently pay a regular dividend.
Are Core Scientific and Amdocs in the same industry?
No. Core Scientific is in the Finance sector, while Amdocs is in Technology.